The use of bone biopsy for histomorphometric analysis is a quantitative histological
examination aimed at obtaining quantitative information on bone remodeling, structure and …

Plasma parathyroid hormone (PTH) concentrations are commonly measured in the context
of CKD, as PTH concentration elevation is typical in this clinical context. Much has been …

Disturbances in mineral and bone metabolism are common in patients with CKD. A large
body of evidence indicates that these derangements are associated with increased mortality …

We evaluated risks associated with elevated alkaline phosphatase in hemodialysis patients
using longitudinal data from the Dialysis Outcomes and Practice Patterns Study, a …

Background: Comparison of renal osteodystrophy in predialysis and hemodialysis has been
rarely reported. Distinct patterns of renal osteodystrophy could be found in these conditions …

BACKGROUND:: Various biochemical markers have been evaluated in dialysis patients for
the diagnosis of renal osteodystrophy (ROD). However, their value in predialysis patients …

Abstract Summary Once-weekly 56.5-μg teriparatide treatment was significantly associated
with the increase in lumbar spine bone mineral density at 48 weeks among hemodialysis …

Osteoprotegerin (OPG) has a profound inhibitory effect on osteoclast differentiation and
bone resorption. Because high-turnover renal osteodystrophy (ROD) is characterized by …

Background. Prednisone is a major factor of bone loss after kidney transplantation. The role
of hyperparathyroidism and immunosuppressors is less clear. Methods. Thirty‐three patients …

Background Parathyroid hormone (PTH) is a cardinal factor in the pathogenesis of bone
disease in the dialysis population. The spectrum of renal osteodystrophy has been reported …